SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-008234
Filing Date
2022-05-11
Accepted
2022-05-11 08:00:57
Documents
72
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bcel-20220331x10q.htm   iXBRL 10-Q 1790677
2 EX-31.1 bcel-20220331xex31d1.htm EX-31.1 12781
3 EX-31.2 bcel-20220331xex31d2.htm EX-31.2 12365
4 EX-32.1 bcel-20220331xex32d1.htm EX-32.1 8260
  Complete submission text file 0001558370-22-008234.txt   6737811

Data Files

Seq Description Document Type Size
5 EX-101.SCH bcel-20220331.xsd EX-101.SCH 43571
6 EX-101.CAL bcel-20220331_cal.xml EX-101.CAL 46796
7 EX-101.DEF bcel-20220331_def.xml EX-101.DEF 206177
8 EX-101.LAB bcel-20220331_lab.xml EX-101.LAB 356511
9 EX-101.PRE bcel-20220331_pre.xml EX-101.PRE 318850
66 EXTRACTED XBRL INSTANCE DOCUMENT bcel-20220331x10q_htm.xml XML 1137844
Mailing Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070 650-595-2595
Atreca, Inc. (Filer) CIK: 0001532346 (see all company filings)

IRS No.: 273723255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38935 | Film No.: 22912120
SIC: 2834 Pharmaceutical Preparations